Deshmukh Umesh S, Bagavant Harini, Sim Davis, Pidiyar Vyankatesh, Fu Shu Man
Specialized Center of Research on Systemic Lupus Erythematosus, Division of Rheumatology and Immunology, Department of Internal Medicine, University of Virginia, Charlottesville, VA 22908, USA.
J Immunol. 2007 Feb 15;178(4):2565-71. doi: 10.4049/jimmunol.178.4.2565.
Autoantibody response against the small nuclear ribonucleoprotein (snRNP) complex is a characteristic feature of systemic lupus erythematosus. The current investigation was undertaken to determine whether activation of SmD-reactive T cells by synthetic peptides harboring T cell epitopes can initiate a B cell epitope spreading cascade within the snRNP complex. T cell epitopes on SmD were mapped in A/J mice and were localized to three regions on SmD, within aa 26-55, 52-69, and 86-115. Immunization with synthetic peptides SmD(31-45), SmD(52-66), and SmD(91-110) induced T and B cell responses to the peptides, with SmD(31-45) inducing the strongest response. However, only SmD(52-66) immunization induced T cells capable of reacting with SmD. Analysis of sera by immunoprecipitation assays showed that intermolecular B cell epitope spreading to U1RNA-associated A ribonucleoprotein and SmB was consistently observed only in the SmD(52-66)-immunized mice. Surprisingly, in these mice, Ab responses to SmD were at low levels and transient. In addition, the sera did not react with other regions on SmD, indicating a lack of intramolecular B cell epitope spreading within SmD. Our study demonstrates that T cell responses to dominant epitope on a protein within a multiantigenic complex are capable of inducing B cell responses to other proteins within the complex. This effect can happen without generating a good Ab response to the protein from which the T epitope was derived. Thus caution must be taken in the identification of Ags responsible for initiating autoimmune responses based solely on serological analysis of patients and animals with systemic autoimmune disorders.
针对小核核糖核蛋白(snRNP)复合物的自身抗体反应是系统性红斑狼疮的一个特征。当前的研究旨在确定携带T细胞表位的合成肽激活SmD反应性T细胞是否能在snRNP复合物内引发B细胞表位扩展级联反应。在A/J小鼠中绘制了SmD上的T细胞表位,并定位到SmD上的三个区域,即氨基酸26 - 55、52 - 69和86 - 115内。用合成肽SmD(31 - 45)、SmD(52 - 66)和SmD(91 - 110)免疫诱导了对这些肽的T细胞和B细胞反应,其中SmD(31 - 45)诱导的反应最强。然而,只有SmD(52 - 66)免疫诱导出了能够与SmD反应的T细胞。通过免疫沉淀试验分析血清表明,仅在SmD(52 - 66)免疫的小鼠中持续观察到分子间B细胞表位扩展到U1RNA相关的A核糖核蛋白和SmB。令人惊讶的是,在这些小鼠中,对SmD的抗体反应水平较低且短暂。此外,血清不与SmD上的其他区域反应,表明在SmD内缺乏分子内B细胞表位扩展。我们的研究表明,对多抗原复合物中一种蛋白质上显性表位的T细胞反应能够诱导对该复合物中其他蛋白质的B细胞反应。这种效应可以在不对产生T表位的蛋白质产生良好抗体反应的情况下发生。因此,在仅基于对患有系统性自身免疫性疾病的患者和动物的血清学分析来鉴定引发自身免疫反应的抗原时必须谨慎。